The prevalence and clinical characteristics of diabetic neuropathy in ...

More documents

Recommendations

Info

$Microsoft PowerPoint - S14-1_\300\374\274\272\277\317 [\310\243 ...$

$Microsoft PowerPoint - src.ppt [\310\243\310\257 \270\360\265\345]$

$Microsoft PowerPoint - S7-1_\300\374\277\353\260\374$

$Microsoft PowerPoint - src.ppt [\310\243\310\257 \270\360\265\345]$

$(Microsoft PowerPoint - WDXKRSAWSXRU.ppt [\310\243\310\257 ...$

DPN: treatmentTreatment (+) Treatment (-)30.2%69.8%local preparationSSRIopiodiSSNRITCAsgamma-linoleic acidanti-convulsant drugalpha-lipoic acid0.0% 20.0% 40.0% 60.0%20.1% patients receivedmore than one medication.DPN patients with treatmenthad longer duration ofdiabetes, more insulin use,and more retinopathy,nephropathy andhypertension.However, mean number ofsite unable to feel themonofilament was higher inDPN patients withouttreatment than those withtreatment (P < 0.001).
Clinical Implications of DPN inKorea
Page 1 and 2: The prevalence and clinicalcharacte
Page 4 and 5: •Diabetes was associated with 2-3
Page 6 and 7: Total medical cost in patients with
Page 8 and 9: DISCLOSUREAnalysis of data from the
Page 10 and 11: Prevalence of diabetic neuropathy i
Page 12 and 13: Prevalence of DPNN = 3,339Non-DPNDP
Page 14 and 15: Clinical characteristics of DPN in
Page 16 and 17: Prevalence of DPN according to thed
Page 18 and 19: Temporal prevalence (%) of diabetic
Page 20 and 21: ORs of risk factors associated with
Page 22 and 23: Comparison of MNSI symptom distribu
Page 26 and 27: BPI-SF (1): Pain severityNon-DPNDPN
Page 28 and 29: MOS-sleep scale• 당신솟이 필
Page 31 and 32: EQ-5D descriptive system: 5 dimensi
Page 33 and 34: Patients awareness of DPNAwarenessY
Page 35 and 36: Investigators and study centersincl
Page 37: Thank you for your attention!

The prevalence and clinical characteristics of diabetic neuropathy in ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?